PDA Spotlight Podcast PDA

In the podcast episode, Merck and Co. Executive Director Ghada Haddad discusses AI and ML and their potential impact on the pharma industry.

In this episode of the PDA Spotlight Podcast, Cristiana Campa, a member of the PDA Board of Directors, discusses the main challenges regarding global and rapid access to medicines and vaccines and how quality-by-design (QbD) could be the game changer.  

In this episode, Bettine Boltres, Director of Scientific Affairs and Technical Solutions, Glass Systems, at West Pharmaceutical Services, gives insight into how early career professionals could start their careers in the pharmaceutical industry.

In this episode, one of the voices of PDA, William Rohrs, sits down with Marc Glogovsky, who is the Manager of the Microbiology Consultant Division at ValSource and one of PDA's Board of Directors, to talk about data integrity in the quality microbiology laboratory.

In this episode, one of the voices of PDA, William Rohrs, sits down with one of PDA's Board of Directors, Andrew Hopkins, to talk about
EU GMP Annex 1: Manufacture of Sterile Medicinal Products. This interview took place at the 2023 PDA/FDA Joint Regulatory Conference with over 800 attendees.

This 40 minute informative episode discusses a range of topics related to working remotely during COVID-19 including: setting up a home office, challenges resulting from remote working, the division between operations and staff functions, opportunities for reimagining the workplace due to this transition, and changes that may become permanent after the pandemic recedes.  The guests for this podcast are Tony Cundell, PhD with Microbiological Consulting, LLC and Callum Chapman with AstraZeneca.  Moderating is Adam Caruso with Merck & Co.

The views and opinions expressed in this podcast are those of the presenters.